Nevro Corp (NVRO)
5.29
+0.09
(+1.73%)
USD |
NYSE |
Sep 27, 16:00
5.285
0.00 (0.00%)
Pre-Market: 20:00
Nevro Research and Development Expense (Annual): 54.42M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 54.42M |
| December 31, 2022 | 53.06M |
| December 31, 2021 | 47.66M |
| December 31, 2020 | 45.60M |
| December 31, 2019 | 59.02M |
| December 31, 2018 | 48.46M |
| Date | Value |
|---|---|
| December 31, 2017 | 37.56M |
| December 31, 2016 | 33.73M |
| December 31, 2015 | 21.38M |
| December 31, 2014 | 19.82M |
| December 31, 2013 | 20.34M |
| December 31, 2012 | 15.66M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
45.60M
Minimum
2020
59.02M
Maximum
2019
51.95M
Average
53.06M
Median
2022
Research and Development Expense (Annual) Benchmarks
| Myomo Inc | 2.636M |
| Inspire Medical Systems Inc | 116.54M |
| Axonics Inc | 34.89M |
| Inari Medical Inc | 87.53M |
| Electromed Inc | 0.656M |